Filters
Price
Category
Peptides
Administration
Dosage
Research Focus
Brand
Rating
Status
Best Sellers
-
Tesamorelin
£22.99 – £90.99Price range: £22.99 through £90.99
-
KLOW80
£74.99
- IGF-1 LR3 £22.99 – £52.99Price range: £22.99 through £52.99
-
KPV
£40.99mg
-
Tirzepatide (Pen)
£54.99 – £74.99Price range: £54.99 through £74.99
Showing all 2 results
Showing all 2 results
IGF-1 LR3
£22.99 – £52.99Price range: £22.99 through £52.99IGF-1 LR3
Growth Factor — IGF-1 Analogue IGF-1 LR3 is a recombinant analogue of insulin-like growth factor 1 with a modified N-terminus (Arg³ substitution) and 13-amino acid extension that dramatically extends half-life. It is 2–3× more potent than native IGF-1 and does not bind IGF binding proteins, making it significantly more bioavailable. Half-Life: ~20–30 hours (vs 15 min native IGF-1) Potency: 2–3× native IGF-1 IGFBP Binding: Reduced — higher free fraction
SLU-PP-332
£79.99SLU-PP-332
Metabolic — Exercise Mimetic / ERR Agonist
Synthetic ERRα/β/γ pan-agonist · small molecule
SLU-PP-332 is a first-in-class synthetic pan-agonist of the oestrogen-related receptor (ERR) family — ERRα, ERRβ, and ERRγ. Developed at Saint Louis University, it activates the same nuclear receptor transcription factors as aerobic exercise, producing measurable improvements in endurance, fat oxidation, and metabolic health in preclinical models without physical activity. It represents one of the most promising “exercise mimetic” compounds in current research.
Class
ERRα/β/γ pan-agonist — small molecule
Developer
Saint Louis University (Bhatt lab)
Stage
Preclinical — 2023/24 landmark studies










